Devyser Diagnostics AB is a Swedish AB based in Årsta, operating in the Activities of holding companies sector. Incorporated in 2004, the company reported revenue of SEK 50.0m in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av Berlin, Anna Sabina Maj Wahlström, Jan Tomas i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall äga och förvalta aktier i andra bolag, bedriva forskning, utveckling, tillverkning och försäljning av diagnostiska tester, konsultverksamhet inom dessa verksamhetsområden samt därmed förenlig verksamhet.
In its most recent annual report (2025), Devyser Diagnostics AB reported revenue of SEK 50.0m, an increase of 6% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 12.0m, and the EBITDA margin stood at 38%.
At the end of 2025, equity financed 98.3% of the balance sheet, and current assets covered short-term debt 9.2 times.
Frequently asked questions
What is the Org number of Devyser Diagnostics AB?
Devyser Diagnostics AB is registered with Bolagsverket / SCB under Org 5566697834.
What is the revenue of Devyser Diagnostics AB?
Devyser Diagnostics AB reported revenue of SEK 50.0m in 2025.
Who is the CEO of Devyser Diagnostics AB?
Jan Tomas Wahlström is the CEO of Devyser Diagnostics AB, in role since 2025.
Who is the chairman of Devyser Diagnostics AB?
Ingrid Mia Arnhult chairs the board of Devyser Diagnostics AB, in role since 2021.
Where is Devyser Diagnostics AB headquartered?
Devyser Diagnostics AB's registered address is Bränningevägen 12.
